Objective: Cardiac transplantation is faced with a decreasing number of donors and a higher proportion of borderline donor hearts. The main cause of early death is donor organ failure, which is more commonly right ventricular (RV) failure for incompletely understood reasons. We aimed to describe the high energy phosphate (HEP) metabolism and endothelial cell activation (ECA) after brain death and subsequently throughout transplantation and to make correlations with functional performance. Patients and methods: Sixty-nine donor hearts (including 6 domino) were studied. Transmural biopsies were taken from both ventricles at 2 time points during the donor operation and repeated 3 times during implantation, in addition, heart transplant patient...
Background: the number of heart transplants is declining since the 2000s because of organ shortage. ...
The ultimate treatment for patients with end-stage heart failure is heart transplantation. The numbe...
Cardiac transplantation is the gold standard treatment for end-stage heart failure. Over the last 4...
OBJECTIVE: Solid organ transplantation is associated with activation of apoptotic pathways and other...
BACKGROUND: Endothelial activation in the donor heart has been described variably after brain death ...
The relationships between high-energy phosphate levels, oxidative insult and mechanical function rep...
Background: To date, there has been little research, if any, on the pathological correlates of end-s...
INTRODUCTION: Primary graft dysfunction (PGD) is a leading cause of 30-day mortality following heart...
Abstract Introduction: Primary graft dysfunction is a major cause of mortality after heart transpla...
PURPOSE: Brain death (BD) causes metabolic and energetic imbalances leading to cardiac dysfunction, ...
International audienceOBJECTIVE: Early graft failure (EGF) is a life-threatening event still account...
Brain stem death is confirmed prior to donation in clinical cardiac transplantation. This condition ...
Heart transplantation provides a substantial survival benefit for selected patients with advanced he...
Donation of organs after circulatory death (DCD) is re-emerging as an important source of organs for...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
Background: the number of heart transplants is declining since the 2000s because of organ shortage. ...
The ultimate treatment for patients with end-stage heart failure is heart transplantation. The numbe...
Cardiac transplantation is the gold standard treatment for end-stage heart failure. Over the last 4...
OBJECTIVE: Solid organ transplantation is associated with activation of apoptotic pathways and other...
BACKGROUND: Endothelial activation in the donor heart has been described variably after brain death ...
The relationships between high-energy phosphate levels, oxidative insult and mechanical function rep...
Background: To date, there has been little research, if any, on the pathological correlates of end-s...
INTRODUCTION: Primary graft dysfunction (PGD) is a leading cause of 30-day mortality following heart...
Abstract Introduction: Primary graft dysfunction is a major cause of mortality after heart transpla...
PURPOSE: Brain death (BD) causes metabolic and energetic imbalances leading to cardiac dysfunction, ...
International audienceOBJECTIVE: Early graft failure (EGF) is a life-threatening event still account...
Brain stem death is confirmed prior to donation in clinical cardiac transplantation. This condition ...
Heart transplantation provides a substantial survival benefit for selected patients with advanced he...
Donation of organs after circulatory death (DCD) is re-emerging as an important source of organs for...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
Background: the number of heart transplants is declining since the 2000s because of organ shortage. ...
The ultimate treatment for patients with end-stage heart failure is heart transplantation. The numbe...
Cardiac transplantation is the gold standard treatment for end-stage heart failure. Over the last 4...